** ponceau 4R: may have an adverse effect on activity and attention in children
However, the best outcomes often come from more than just TRT alone
GLP-1 Receptor Agonist Use Linked to Reduced Risks for Substance Use Disorder MONDAY, March 9, 2026 -- The use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with reduced risks for developing substance use disorders (SUDs), according to a study published online March 4 in The BMJ
References Do, D., Lee, T., Peasah, S
Introduction Glutathione has become a premium cosmetic ingredient in modern skin-care formulations, thanks to its dual role as a powerful antioxidant and a well-recognized skin-brightening agent